An additional and complementary role for IL25-responsive ILC2 has recently been identified in the APC1322T/+ mouse model of intestinal polyposis, where iILC2-dependent activation of immune suppressive myeloid-derived suppressor cells (MDSC) served as a promoter of intestinal adenomas, resulting in impaired survival69. This evidence concerns the gene IL25 and gastrointestinal polyp.